Isoray to Participate in the Oppenheimer 32nd Annual Healthcare Conference
Isoray, Inc. (NYSE American: ISR) announced that CEO Lori Woods will speak at the Oppenheimer 32nd Annual Healthcare Conference on March 17 at 1:20 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray, Inc. (NYSE American: ISR) announced that CEO Lori Woods will speak at the Oppenheimer 32nd Annual Healthcare Conference on March 17 at 1:20 p.m. ET. The event will be a virtual fireside chat, with the opportunity for institutional investors to engage in one-on-one and group meetings with CEO Woods and CFO Jonathan Hunt.
A live webcast will be available on Isoray’s Investor Relations page, with an on-demand replay accessible for 90 days post-event.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was +2.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RICHLAND, Wash., March 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy, today announced that Chief Executive Officer Lori Woods will participate in a virtual fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on Thursday, March 17 at 1:20 p.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.
A live webcast of the virtual fireside chat will be available on Isoray’s Investor Relations section of the Company’s website at https://isoray.com/investors/presentations/. An on-demand replay will be available shortly after the conclusion on the Investor Relations section of the website and will be available for 90 days.
About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.